Depreciation of Akero Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Akero Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
Akero Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2024 was $1,000, a 91% decline year-over-year.
Akero Therapeutics, Inc. annual Depreciation for 2024 was $18,000, a 38% decline from 2023.
Akero Therapeutics, Inc. annual Depreciation for 2023 was $29,000, a 33% decline from 2022.
Akero Therapeutics, Inc. annual Depreciation for 2022 was $43,000, a 4.9% increase from 2021.
Source SEC data: View on sec.gov

Depreciation, Annual (USD)

Depreciation, YoY Annual Change (%)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Change (%)

Akero Therapeutics, Inc. Annual Depreciation (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$18,000	-$11,000	-38%	01 Jan 2024	31 Dec 2024	10-K	28 Feb 2025	2024	FY
2023	$29,000	-$14,000	-33%	01 Jan 2023	31 Dec 2023	10-K	28 Feb 2025	2024	FY
2022	$43,000	+$2,000	+4.9%	01 Jan 2022	31 Dec 2022	10-K	28 Feb 2025	2024	FY
2021	$41,000	+$24,000	+141%	01 Jan 2021	31 Dec 2021	10-K	29 Feb 2024	2023	FY
2020	$17,000			01 Jan 2020	31 Dec 2020	10-K	25 Feb 2022	2021	FY

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$1,000	-$10,000	-91%	01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q1 2023	$11,000	$0	0%	01 Jan 2023	31 Mar 2023	10-Q	10 May 2024	2024	Q1
Q1 2022	$11,000	$0	0%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q1 2021	$11,000			01 Jan 2021	31 Mar 2021	10-Q	06 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.